Generated: April 25, 2017
|Title:||Method of lowering intraocular pressure using phenylimino-imidazoles|
|Abstract:||A method is provided of treating glaucoma in a patient which comprises administering, preferably as eye drops, an effective amount of the compound ##STR1## which is preferably in the form of its hydrochloride. The compound is administered preferably in the form of a sterile pharmacologically acceptable solution which contains from 0.1 to 5, and more preferably 0.1 to 2.0, percent by weight of said compound. The patient preferably obtains the anti-glaucoma agent in the form of a kit which comprises the sterile pharmacologically acceptable solution and an eyedropper for dispensing said sterile pharmacologically acceptable solution to the affected eyes of a patient suffering from glaucoma.|
|Inventor(s):||Cavero; Icilio (94000 Creteil, FR), Langer; Salomon Z. (75017 Paris, FR), York, Jr.; Billie M. (Fort Worth, TX)|
|Filing Date:||Aug 03, 1983|
|Claims:||1. A method for lowering intraocular pressure comprising topically applying to the eye an effective amount for lowering such intraocular pressure of a compound of the formula ##STR25## or a pharmaceutically acceptable salt thereof. |
2. A method according to claim 1, which comprises applying said compound in the form of eye drops.
3. A method according to claim 2 wherein said compound comprises from about 0.10 to about 2.0 percent by weight of said eye drops.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.